Commercial Portfolio & Lifecycle Manager

Salary Range: €58,200.00 - €108,000.00

What we offer

• The opportunity to join a newly created strategic unit with the ability to influence key business decisions at Novartis Spain.
• A role with wide exposure to brands, therapeutic areas, and functions.
• Direct interaction with senior leaders and decision-makers from various functions.
• The opportunity to shape how Portfolio and Life Cycle Management is built and integrated within the Spanish organization.
• Participation in high-impact initiatives with direct implications for the long-term growth, profitability, and sustainability of the portfolio.
• A dynamic environment, ideal for people with strategic ambition, intellectual curiosity, and a strong value-creation mindset.
• Professional development opportunities in a leading international pharmaceutical company.

The Commercial Portfolio Unit is a newly established strategic unit within Novartis Spain. Its mission is to maximise the contribution of the Rest of Portfolio to the business by identifying, prioritising and activating the opportunities with the greatest potential to create or protect value.

Taking a cross-portfolio perspective, the unit brings together commercial, financial, market access, regulatory and operational considerations to support better business decisions and turn portfolio complexity into sustainable growth.

About the Commercial Portfolio Unit

The Commercial Portfolio Unit is a newly created strategic unit within Novartis Spain. Its mission is to maximize the contribution of the Rest of Portfolio to the business by identifying, prioritizing, and activating the opportunities with the greatest potential to create or protect value.

With a cross-functional perspective of the portfolio, the unit integrates commercial, financial, market access, regulatory, and operational considerations to support better business decisions and convert portfolio complexity into sustainable growth.

Purpose of the role

The Portfolio & Life-Cycle Management Lead will act as a catalyst for strategic business decisions across the entire portfolio.

The role will continuously evaluate portfolio performance, market dynamics, and critical life cycle milestones to identify opportunities that accelerate growth, improve profitability, protect value, and mitigate risks. It will translate insights into clear recommendations, solid business cases, and executable plans.

The selected person will also play a central role in building and integrating Portfolio and Life Cycle Management as a strategic capability within Novartis Spain. This includes establishing decision-making frameworks, governance mechanisms, and cross-functional ways of working that strengthen portfolio prioritization and execution.

This is not a traditional single-brand management role. It requires a corporate vision, solid business judgment, and the ability to influence decisions across functions and therapeutic areas without formal authority.

Key responsibilities

Portfolio strategy and opportunity identification

• Conduct proactive and continuous portfolio reviews to identify opportunities for growth, value protection, efficiency, and risk mitigation.
• Evaluate the performance, future potential, and strategic relevance of brands at different stages of their life cycle.
• Translate portfolio insights into clear strategic priorities and actionable business recommendations.
• Evaluate and prioritize opportunities based on their potential impact, feasibility, investment level, expected return, and associated risks.
• Develop business cases, financial evaluations, and scenarios to support resource allocation and investment decisions.
• Monitor the implementation and business impact of prioritized portfolio initiatives.

Life cycle management and LoE preparedness

• Anticipate critical product life cycle milestones, including loss of exclusivity (LoE), changes in market dynamics, and changes in the competitive, regulatory, or access environment.
• Develop differentiated life cycle strategies based on the maturity, performance, and strategic relevance of each brand.
• Develop structured LoE preparedness and risk mitigation plans, in collaboration with the relevant cross-functional teams.
• Identify and activate value optimization levers in areas such as pricing, supply strategy, demand management, brand maintenance, operating model simplification, and resource allocation.
• Support the transition of brands to the Commercial Portfolio Unit, ensuring an effective transfer of business knowledge, performance insights, responsibilities, and strategic priorities.
• Identify opportunities to simplify, outsource, or rationalize certain portfolio activities or assets where appropriate.

Cross-functional leadership and execution

• Lead the evaluation, prioritization, and activation of cross-functional portfolio initiatives.
• Bring Marketing, Market Access, Finance, Regulatory Affairs, Supply, Legal, and other relevant functions together around a common database and recommendation.
• Generate alignment among stakeholders with differing objectives, perspectives, and incentives.
• Constructively challenge existing assumptions and ways of working to find better solutions for the business.
• Present portfolio recommendations, business cases, and strategic trade-offs to senior stakeholders and decision forums.
• Ensure that agreed priorities are translated into clear owners, implementation plans, and monitoring mechanisms.

Capability development and organizational transformation

• Contribute to consolidating the Commercial Portfolio Unit as a strategic portfolio management capability within Novartis Spain.
• Design and implement portfolio management frameworks, governance forums, tools, processes, and decision criteria.
• Promote a culture of value creation, prioritization, simplification, and data-driven decision-making.
• Act as an internal reference for Portfolio and Life Cycle Management.
• Foster collaboration and knowledge sharing between therapeutic areas and functions.
• Identify opportunities to strengthen portfolio management capabilities through new approaches, analytics, technologies, and ways of working.

Technical and business capabilities

• Strategic management of the portfolio and product life cycle.
• Identification, evaluation, and sizing of opportunities.
• Business case development and financial evaluation.
• Scenario modeling and risk assessment.
• Market, customer, and competitor analysis.
• Portfolio prioritization and resource allocation decisions.
• Interpretation of commercial and financial data.
• Leadership of cross-functional programs and projects.
• Translation of insights into actionable business recommendations.

Leadership capabilities and mindset

• Strategic thinking and solid business judgment.
• Ability to connect the global portfolio vision with concrete business actions.
• Strong analytical skills and the ability to make decisions with incomplete information.
• Critical thinking and the confidence to constructively challenge established assumptions.
• Ability to influence, generate alignment, and drive progress without formal authority.
• Clear and compelling communication, with storytelling skills.
• Strong stakeholder management skills.
• Pragmatism, accountability, and a strong orientation toward execution.
• Intellectual curiosity and openness to new approaches and technologies.
• Ability to navigate ambiguity and create structure, priorities, and action plans.
• Corporate mindset, with the ability to prioritize the global value of the portfolio over individual brand interests.